T2 Biosystems, Inc. - Common Stock (TTOO)
0.2150
+0.0050 (2.38%)
T2 Biosystems is a biotechnology company focused on transforming the way infectious diseases are diagnosed
The company's innovative molecular diagnostic platform enables rapid and accurate detection of a wide range of pathogens, including bacteria and fungi, using blood samples. By providing timely results, T2 Biosystems aims to enhance clinical decision-making, improve patient outcomes, and reduce the overall burden of infectious diseases. Their commitment to developing advanced diagnostic tools positions them as a leader in the field of point-of-care testing and infectious disease management.
